Dr Lee Fairlie is Director: Child & Adolescent Health at the Wits Reproductive Health and HIV Institute. She has significant experience in clinical care and clinical trials in paediatric and adolescent HIV and co-morbidities, including TB. She has been an investigator in clinical research trials since 2007, including International Maternal Paediatric Adolescent AIDS Clinical Trials Network (IMPAACT) studies; a global network for HIV and TB prevention and treatment research for infants, children adolescents and pregnant women; and non-NIH studies in paediatrics, adolescents and pregnant women. She is the Shandukani Research Centre Leader and Investigator of Record on a number of studies, including Phase I/II pharmacokinetic studies, PMTCT studies, neurodevelopment studies, and vaccine studies involving children and pregnant women. She serves on the National HIV Guideline Committees for Children and Adolescents.
Dr Fairlie is leading the recently awarded “Paediatric and Adolescent Scale-up Plan” project to increase HIV testing and TB screening in children and adolescents, with linkage to care, initiation of ART, retention and virological suppression on ART in the City of Johannesburg and additional work investigating mother-infant pairs in the inner city of Johannesburg.